ID   ACON_HUMAN              Reviewed;         780 AA.
AC   Q99798; O75809; Q5JZ41; Q6FHX0; Q8TAQ6;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   28-JUN-2023, entry version 215.
DE   RecName: Full=Aconitate hydratase, mitochondrial;
DE            Short=Aconitase;
DE            EC=4.2.1.3 {ECO:0000250|UniProtKB:P16276};
DE   AltName: Full=Citrate hydro-lyase;
DE   Flags: Precursor;
GN   Name=ACO2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Skeletal muscle;
RA   Juang H.H., Chiou B.;
RT   "Cloning and structural characterization of human mitochondrial
RT   aconitase.";
RL   Submitted (DEC-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9630632; DOI=10.1016/s0378-1119(98)00188-7;
RA   Mirel D.B., Marder K., Graziano J., Freyer G., Zhao Q., Mayeux R.,
RA   Wilhelmsen K.C.;
RT   "Characterization of the human mitochondrial aconitase gene (ACO2).";
RL   Gene 213:205-218(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P.,
RA   Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y.,
RA   LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 69-84; 234-245; 313-323; 379-395; 412-424; 430-437;
RP   507-520; 565-573; 608-628; 634-648 AND 657-671, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   PROTEIN SEQUENCE OF 69-83; 96-107; 371-396 AND 524-534.
RX   PubMed=1946331;
RA   Baldwin G.S., Seet K.L., Callaghan J., Toncich G., Toh B.H., Moritz R.L.,
RA   Rubira M.R., Simpson R.;
RT   "Purification and partial amino acid sequence of human aconitase.";
RL   Protein Seq. Data Anal. 4:63-67(1991).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-573 AND LYS-605, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-559, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-559, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   INVOLVEMENT IN OPA9, INVOLVEMENT IN ICRD, VARIANTS OPA9 VAL-74 AND ARG-661,
RP   AND VARIANTS ICRD ASP-259 AND ASN-736.
RX   PubMed=25351951; DOI=10.1136/jmedgenet-2014-102532;
RA   Metodiev M.D., Gerber S., Hubert L., Delahodde A., Chretien D., Gerard X.,
RA   Amati-Bonneau P., Giacomotto M.C., Boddaert N., Kaminska A., Desguerre I.,
RA   Amiel J., Rio M., Kaplan J., Munnich A., Rotig A., Rozet J.M., Besmond C.;
RT   "Mutations in the tricarboxylic acid cycle enzyme, aconitase 2, cause
RT   either isolated or syndromic optic neuropathy with encephalopathy and
RT   cerebellar atrophy.";
RL   J. Med. Genet. 51:834-838(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   VARIANT [LARGE SCALE ANALYSIS] ASN-697.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [17]
RP   VARIANT ICRD ARG-112, AND CHARACTERIZATION OF VARIANT ICRD ARG-112.
RX   PubMed=22405087; DOI=10.1016/j.ajhg.2012.01.009;
RA   Spiegel R., Pines O., Ta-Shma A., Burak E., Shaag A., Halvardson J.,
RA   Edvardson S., Mahajna M., Zenvirt S., Saada A., Shalev S., Feuk L.,
RA   Elpeleg O.;
RT   "Infantile cerebellar-retinal degeneration associated with a mutation in
RT   mitochondrial aconitase, ACO2.";
RL   Am. J. Hum. Genet. 90:518-523(2012).
CC   -!- FUNCTION: Catalyzes the isomerization of citrate to isocitrate via cis-
CC       aconitate. {ECO:0000250|UniProtKB:P16276}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=citrate = D-threo-isocitrate; Xref=Rhea:RHEA:10336,
CC         ChEBI:CHEBI:15562, ChEBI:CHEBI:16947; EC=4.2.1.3;
CC         Evidence={ECO:0000250|UniProtKB:P16276};
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC         Evidence={ECO:0000250|UniProtKB:P16276};
CC       Note=Binds 1 [4Fe-4S] cluster per subunit. Binding of a [3Fe-4S]
CC       cluster leads to an inactive enzyme. {ECO:0000250|UniProtKB:P16276};
CC   -!- PATHWAY: Carbohydrate metabolism; tricarboxylic acid cycle; isocitrate
CC       from oxaloacetate: step 2/2.
CC   -!- SUBUNIT: Monomer. {ECO:0000250|UniProtKB:P16276}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250|UniProtKB:P16276}.
CC   -!- PTM: Forms covalent cross-links mediated by transglutaminase TGM2,
CC       between a glutamine and the epsilon-amino group of a lysine residue,
CC       forming homopolymers and heteropolymers.
CC       {ECO:0000250|UniProtKB:Q9ER34}.
CC   -!- DISEASE: Infantile cerebellar-retinal degeneration (ICRD) [MIM:614559]:
CC       A severe autosomal recessive neurodegenerative disorder characterized
CC       by onset between ages 2 and 6 months of truncal hypotonia, athetosis,
CC       seizures, and ophthalmologic abnormalities, particularly optic atrophy
CC       and retinal degeneration. Affected individuals show profound
CC       psychomotor retardation, with only some achieving rolling, sitting, or
CC       recognition of family. Brain MRI shows progressive cerebral and
CC       cerebellar degeneration. {ECO:0000269|PubMed:22405087,
CC       ECO:0000269|PubMed:25351951}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Optic atrophy 9 (OPA9) [MIM:616289]: A condition that features
CC       progressive visual loss in association with optic atrophy. Atrophy of
CC       the optic disk indicates a deficiency in the number of nerve fibers
CC       which arise in the retina and converge to form the optic disk, optic
CC       nerve, optic chiasm and optic tracts. {ECO:0000269|PubMed:25351951}.
CC       Note=The disease is caused by variants affecting the gene represented
CC       in this entry.
CC   -!- SIMILARITY: Belongs to the aconitase/IPM isomerase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Aconitase entry;
CC       URL="https://en.wikipedia.org/wiki/Aconitase";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U80040; AAB38416.1; -; mRNA.
DR   EMBL; U87939; AAC39921.1; -; Genomic_DNA.
DR   EMBL; U87926; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; U87927; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; U87928; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; U87929; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; U87930; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; U87931; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; U87932; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; U87933; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; U87934; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; U87935; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; U87936; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; U87937; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; U87938; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; CR456365; CAG30251.1; -; mRNA.
DR   EMBL; CR536568; CAG38805.1; -; mRNA.
DR   EMBL; AL023553; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL008582; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC014092; AAH14092.1; -; mRNA.
DR   EMBL; BC026196; AAH26196.1; -; mRNA.
DR   CCDS; CCDS14017.1; -.
DR   PIR; S17526; S17526.
DR   PIR; T52543; T52543.
DR   RefSeq; NP_001089.1; NM_001098.2.
DR   AlphaFoldDB; Q99798; -.
DR   SMR; Q99798; -.
DR   BioGRID; 106566; 205.
DR   IntAct; Q99798; 15.
DR   MINT; Q99798; -.
DR   STRING; 9606.ENSP00000216254; -.
DR   DrugBank; DB03964; 4-Hydroxy-Aconitate Ion.
DR   DrugBank; DB04351; Aconitate Ion.
DR   DrugBank; DB04072; Alpha-Methylisocitric Acid.
DR   DrugBank; DB01727; Isocitric Acid.
DR   DrugBank; DB04562; Tricarballylic acid.
DR   CarbonylDB; Q99798; -.
DR   GlyCosmos; Q99798; 1 site, 1 glycan.
DR   GlyGen; Q99798; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q99798; -.
DR   PhosphoSitePlus; Q99798; -.
DR   SwissPalm; Q99798; -.
DR   BioMuta; ACO2; -.
DR   DMDM; 6686275; -.
DR   DOSAC-COBS-2DPAGE; Q99798; -.
DR   REPRODUCTION-2DPAGE; IPI00017855; -.
DR   REPRODUCTION-2DPAGE; Q99798; -.
DR   SWISS-2DPAGE; Q99798; -.
DR   UCD-2DPAGE; Q99798; -.
DR   CPTAC; CPTAC-2717; -.
DR   EPD; Q99798; -.
DR   jPOST; Q99798; -.
DR   MassIVE; Q99798; -.
DR   MaxQB; Q99798; -.
DR   PaxDb; Q99798; -.
DR   PeptideAtlas; Q99798; -.
DR   ProteomicsDB; 78478; -.
DR   Antibodypedia; 240; 582 antibodies from 39 providers.
DR   DNASU; 50; -.
DR   Ensembl; ENST00000216254.9; ENSP00000216254.4; ENSG00000100412.17.
DR   GeneID; 50; -.
DR   KEGG; hsa:50; -.
DR   MANE-Select; ENST00000216254.9; ENSP00000216254.4; NM_001098.3; NP_001089.1.
DR   UCSC; uc003bac.3; human.
DR   AGR; HGNC:118; -.
DR   CTD; 50; -.
DR   DisGeNET; 50; -.
DR   GeneCards; ACO2; -.
DR   HGNC; HGNC:118; ACO2.
DR   HPA; ENSG00000100412; Tissue enhanced (heart muscle, skeletal muscle, tongue).
DR   MalaCards; ACO2; -.
DR   MIM; 100850; gene.
DR   MIM; 614559; phenotype.
DR   MIM; 616289; phenotype.
DR   neXtProt; NX_Q99798; -.
DR   OpenTargets; ENSG00000100412; -.
DR   Orphanet; 98676; Autosomal recessive isolated optic atrophy.
DR   Orphanet; 313850; Infantile cerebellar-retinal degeneration.
DR   PharmGKB; PA24443; -.
DR   VEuPathDB; HostDB:ENSG00000100412; -.
DR   eggNOG; KOG0453; Eukaryota.
DR   GeneTree; ENSGT00940000154892; -.
DR   HOGENOM; CLU_006714_2_2_1; -.
DR   InParanoid; Q99798; -.
DR   OrthoDB; 3266779at2759; -.
DR   PhylomeDB; Q99798; -.
DR   TreeFam; TF300627; -.
DR   BioCyc; MetaCyc:HS02077-MON; -.
DR   BRENDA; 4.2.1.3; 2681.
DR   PathwayCommons; Q99798; -.
DR   Reactome; R-HSA-1268020; Mitochondrial protein import.
DR   Reactome; R-HSA-71403; Citric acid cycle (TCA cycle).
DR   SignaLink; Q99798; -.
DR   SIGNOR; Q99798; -.
DR   UniPathway; UPA00223; UER00718.
DR   BioGRID-ORCS; 50; 406 hits in 1181 CRISPR screens.
DR   ChiTaRS; ACO2; human.
DR   GenomeRNAi; 50; -.
DR   Pharos; Q99798; Tbio.
DR   PRO; PR:Q99798; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; Q99798; protein.
DR   Bgee; ENSG00000100412; Expressed in heart right ventricle and 199 other tissues.
DR   ExpressionAtlas; Q99798; baseline and differential.
DR   Genevisible; Q99798; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; HDA:UniProtKB.
DR   GO; GO:0051538; F:3 iron, 4 sulfur cluster binding; IEA:Ensembl.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IBA:GO_Central.
DR   GO; GO:0003994; F:aconitate hydratase activity; EXP:Reactome.
DR   GO; GO:0047780; F:citrate dehydratase activity; IEA:UniProtKB-EC.
DR   GO; GO:0005506; F:iron ion binding; IDA:MGI.
DR   GO; GO:0006101; P:citrate metabolic process; IDA:MGI.
DR   GO; GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc.
DR   GO; GO:0006102; P:isocitrate metabolic process; IEA:Ensembl.
DR   GO; GO:0001889; P:liver development; IEA:Ensembl.
DR   GO; GO:0035900; P:response to isolation stress; IEA:Ensembl.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; IDA:MGI.
DR   CDD; cd01578; AcnA_Mitochon_Swivel; 1.
DR   CDD; cd01584; AcnA_Mitochondrial; 1.
DR   Gene3D; 3.40.1060.10; Aconitase, Domain 2; 1.
DR   Gene3D; 3.30.499.10; Aconitase, domain 3; 2.
DR   Gene3D; 3.20.19.10; Aconitase, domain 4; 1.
DR   InterPro; IPR015931; Acnase/IPM_dHydase_lsu_aba_1/3.
DR   InterPro; IPR001030; Acoase/IPM_deHydtase_lsu_aba.
DR   InterPro; IPR015928; Aconitase/3IPM_dehydase_swvl.
DR   InterPro; IPR018136; Aconitase_4Fe-4S_BS.
DR   InterPro; IPR036008; Aconitase_4Fe-4S_dom.
DR   InterPro; IPR015932; Aconitase_dom2.
DR   InterPro; IPR006248; Aconitase_mito-like.
DR   InterPro; IPR000573; AconitaseA/IPMdHydase_ssu_swvl.
DR   PANTHER; PTHR43160; ACONITATE HYDRATASE B; 1.
DR   PANTHER; PTHR43160:SF3; ACONITATE HYDRATASE, MITOCHONDRIAL; 1.
DR   Pfam; PF00330; Aconitase; 1.
DR   Pfam; PF00694; Aconitase_C; 1.
DR   PRINTS; PR00415; ACONITASE.
DR   SUPFAM; SSF53732; Aconitase iron-sulfur domain; 1.
DR   SUPFAM; SSF52016; LeuD/IlvD-like; 1.
DR   PROSITE; PS00450; ACONITASE_1; 1.
DR   PROSITE; PS01244; ACONITASE_2; 1.
DR   TIGRFAMs; TIGR01340; aconitase_mito; 1.
PE   1: Evidence at protein level;
KW   4Fe-4S; Acetylation; Direct protein sequencing; Disease variant; Iron;
KW   Iron-sulfur; Lyase; Metal-binding; Mitochondrion; Neurodegeneration;
KW   Phosphoprotein; Reference proteome; Transit peptide;
KW   Tricarboxylic acid cycle.
FT   TRANSIT         1..27
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000250"
FT   CHAIN           28..780
FT                   /note="Aconitate hydratase, mitochondrial"
FT                   /id="PRO_0000000541"
FT   REGION          528..560
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        545..560
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         99
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         192..194
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         385
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /evidence="ECO:0000250"
FT   BINDING         448
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /evidence="ECO:0000250"
FT   BINDING         451
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /evidence="ECO:0000250"
FT   BINDING         474
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         479
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         607
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         670..671
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         31
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KI0"
FT   MOD_RES         50
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KI0"
FT   MOD_RES         50
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KI0"
FT   MOD_RES         138
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KI0"
FT   MOD_RES         138
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KI0"
FT   MOD_RES         144
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KI0"
FT   MOD_RES         144
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KI0"
FT   MOD_RES         233
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KI0"
FT   MOD_RES         233
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KI0"
FT   MOD_RES         411
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KI0"
FT   MOD_RES         549
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KI0"
FT   MOD_RES         559
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         573
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         573
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KI0"
FT   MOD_RES         577
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KI0"
FT   MOD_RES         591
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KI0"
FT   MOD_RES         605
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         605
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KI0"
FT   MOD_RES         628
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KI0"
FT   MOD_RES         670
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KI0"
FT   MOD_RES         689
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KI0"
FT   MOD_RES         723
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KI0"
FT   MOD_RES         723
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KI0"
FT   MOD_RES         730
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KI0"
FT   MOD_RES         730
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KI0"
FT   MOD_RES         736
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KI0"
FT   MOD_RES         739
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KI0"
FT   MOD_RES         743
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KI0"
FT   VARIANT         74
FT                   /note="L -> V (in OPA9; dbSNP:rs141772938)"
FT                   /evidence="ECO:0000269|PubMed:25351951"
FT                   /id="VAR_073435"
FT   VARIANT         112
FT                   /note="S -> R (in ICRD; functional expression studies in
FT                   yeast show that the mutant has decreased function under
FT                   growth conditions requiring the TCA cycle and the
FT                   glyoxylate shunt; dbSNP:rs786200924)"
FT                   /evidence="ECO:0000269|PubMed:22405087"
FT                   /id="VAR_067543"
FT   VARIANT         259
FT                   /note="G -> D (in ICRD; dbSNP:rs786204828)"
FT                   /evidence="ECO:0000269|PubMed:25351951"
FT                   /id="VAR_073436"
FT   VARIANT         661
FT                   /note="G -> R (in OPA9; dbSNP:rs752034900)"
FT                   /evidence="ECO:0000269|PubMed:25351951"
FT                   /id="VAR_073437"
FT   VARIANT         697
FT                   /note="T -> N (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036572"
FT   VARIANT         736
FT                   /note="K -> N (in ICRD; dbSNP:rs786204829)"
FT                   /evidence="ECO:0000269|PubMed:25351951"
FT                   /id="VAR_073438"
FT   VARIANT         768
FT                   /note="A -> S (in dbSNP:rs1804785)"
FT                   /id="VAR_033297"
FT   CONFLICT        35
FT                   /note="S -> T (in Ref. 1; AAB38416)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        136
FT                   /note="G -> D (in Ref. 1; AAB38416)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        159
FT                   /note="A -> D (in Ref. 1; AAB38416)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        167
FT                   /note="K -> S (in Ref. 1; AAB38416)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        199
FT                   /note="G -> D (in Ref. 4; CAG38805)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        207
FT                   /note="G -> R (in Ref. 6; AAH26196)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        242
FT                   /note="S -> T (in Ref. 1; AAB38416)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        270
FT                   /note="P -> H (in Ref. 6; AAH26196)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        275
FT                   /note="I -> M (in Ref. 1; AAB38416)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        444
FT                   /note="L -> P (in Ref. 4; CAG38805)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        517
FT                   /note="T -> K (in Ref. 1; AAB38416)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        553
FT                   /note="G -> R (in Ref. 1; AAB38416)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   780 AA;  85425 MW;  58C9FFBDBDC63D5E CRC64;
     MAPYSLLVTR LQKALGVRQY HVASVLCQRA KVAMSHFEPN EYIHYDLLEK NINIVRKRLN
     RPLTLSEKIV YGHLDDPASQ EIERGKSYLR LRPDRVAMQD ATAQMAMLQF ISSGLSKVAV
     PSTIHCDHLI EAQVGGEKDL RRAKDINQEV YNFLATAGAK YGVGFWKPGS GIIHQIILEN
     YAYPGVLLIG TDSHTPNGGG LGGICIGVGG ADAVDVMAGI PWELKCPKVI GVKLTGSLSG
     WSSPKDVILK VAGILTVKGG TGAIVEYHGP GVDSISCTGM ATICNMGAEI GATTSVFPYN
     HRMKKYLSKT GREDIANLAD EFKDHLVPDP GCHYDQLIEI NLSELKPHIN GPFTPDLAHP
     VAEVGKVAEK EGWPLDIRVG LIGSCTNSSY EDMGRSAAVA KQALAHGLKC KSQFTITPGS
     EQIRATIERD GYAQILRDLG GIVLANACGP CIGQWDRKDI KKGEKNTIVT SYNRNFTGRN
     DANPETHAFV TSPEIVTALA IAGTLKFNPE TDYLTGTDGK KFRLEAPDAD ELPKGEFDPG
     QDTYQHPPKD SSGQHVDVSP TSQRLQLLEP FDKWDGKDLE DLQILIKVKG KCTTDHISAA
     GPWLKFRGHL DNISNNLLIG AINIENGKAN SVRNAVTQEF GPVPDTARYY KKHGIRWVVI
     GDENYGEGSS REHAALEPRH LGGRAIITKS FARIHETNLK KQGLLPLTFA DPADYNKIHP
     VDKLTIQGLK DFTPGKPLKC IIKHPNGTQE TILLNHTFNE TQIEWFRAGS ALNRMKELQQ
//
